ZNF175 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.836000E-01
Normal-vs-Stage2
3.174000E-01
Normal-vs-Stage3
7.800300E-02
Normal-vs-Stage4
8.725000E-01
Stage1-vs-Stage2
4.190800E-01
Stage1-vs-Stage3
1.586220E-01
Stage1-vs-Stage4
8.403000E-01
Stage2-vs-Stage3
4.075200E-01
Stage2-vs-Stage4
3.632600E-01
Stage3-vs-Stage4
1.843230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.532200E-01
Normal-vs-AfricanAmerican
4.188600E-01
Normal-vs-Asian
5.675700E-02
Caucasian-vs-AfricanAmerican
9.737000E-01
Caucasian-vs-Asian
1.933440E-01
AfricanAmerican-vs-Asian
3.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.673400E-01
Normal-vs-Female
2.439800E-01
Male-vs-Female
8.438400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.949600E-01
Normal-vs-Age(41-60Yrs)
5.680000E-01
Normal-vs-Age(61-80Yrs)
2.428400E-01
Normal-vs-Age(81-100Yrs)
2.266300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.793600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.162800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.235600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.056800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.379900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.191210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.449600E-02
Normal-vs-Daily Drinker
1.279610E-01
Normal-vs-Weekly Drinker
1.167360E-01
Normal-vs-Occasional Drinker
9.058600E-01
Normal-vs-Social Drinker
2.498400E-01
Non Drinker-vs-Daily Drinker
6.938000E-01
Non Drinker-vs-Weekly Drinker
3.695600E-01
Non Drinker-vs-Occasional Drinker
8.088100E-02
Non Drinker-vs-Social Drinker
2.906800E-01
Daily Drinker-vs-Weekly Drinker
5.946600E-01
Daily Drinker-vs-Occasional Drinker
1.275820E-01
Daily Drinker-vs-Social Drinker
4.887800E-01
Weekly Drinker-vs-Occasional Drinker
2.144000E-01
Weekly Drinker-vs-Social Drinker
8.393400E-01
Occasional Drinker-vs-Social Drinker
2.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.017200E-01
Normal-vs-Grade 2
1.577960E-01
Normal-vs-Grade 3
1.024840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.097600E-01
Grade 1-vs-Grade 3
6.663800E-01
Grade 1-vs-Grade 4
2.017200E-01
Grade 2-vs-Grade 3
6.519200E-01
Grade 2-vs-Grade 4
1.577960E-01
Grade 3-vs-Grade 4
1.024840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.637500E-02
Normal-vs-NonDiabetic
2.751400E-01
Diabetic-vs-NonDiabetic
3.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.018290E-03
Normal-vs-NoPancreatitis
2.650000E-01
Pancreatitis-vs-NoPancreatitis
1.443580E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.117800E-01
Normal-vs-N1
3.594000E-01
N0-vs-N1
5.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.616200E-01
Normal-vs-TP53-NonMutant
6.133200E-01
TP53-Mutant-vs-TP53-NonMutant
4.200800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
